Evidence map›Paper›PMID 41536289›Full record

ArticleACS pharmacology & translational science2026

A Microfibrous Extracellular Matrix Platform for

Navneet Kaur, Mary Jean Savitsky, Michael Lipscomb, Dazhi Yang, Jamel Ali

Abstract read
In one paragraph

Article in ACS pharmacology & translational science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Navneet KaurDepartment of Chemical and Biomedical Engineering, FAMU-FSU College of Engineering, Tallahassee, Florida 32310, United States.ORCID https://orcid.org/0000-0003-4543-370X
Mary Jean SavitskyDepartment of Chemical and Biomedical Engineering, FAMU-FSU College of Engineering, Tallahassee, Florida 32310, United States.
Michael LipscombDepartment of Pharmacology, University of Minnesota, Minneapolis, Minnesota 55455, United States.
Dazhi YangAcrogenic Technologies Inc., Rockville, Maryland 20850, United States.
Jamel AliDepartment of Chemical and Biomedical Engineering, FAMU-FSU College of Engineering, Tallahassee, Florida 32310, United States.ORCID https://orcid.org/0000-0002-2997-1981

Funding

Engineering a Novel Bio-Scaffold for Hepatic Tissue Restoration and Drug ScreeningR16GM145595 · NIGMS · FLORIDA AGRICULTURAL AND MECHANICAL UNIV · PI ALI, JAMEL · 2022 to 2025
$690k
NIGMS NIH HHS R16 GM145595
6 · The paper itself

Abstract

Drug-induced hepatotoxicity is a significant concern in drug development and patient safety. The liver, responsible for drug metabolism, can suffer from damage caused by certain medications, leading to inflammation, cellular damage, and even failure. Traditional two-dimensional (2D) cell cultures fail to replicate the complex

Indexed as

drug-induced liver toxicityextracellular matrixhepatocyteshepatotoxicityliver tissue engineeringspheroids

Identifiers

PMID41536289
PMCPMC12797168

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.